Aortic Stiffness is Associated with Cardiac Function and Cerebral Small Vessel Disease in Patients with Type 1 Diabetes Mellitus: Assessment by Magnetic Resonance Imaging

Overview

Journal Eur Radiol

Specialty Radiology

Date 2009 Nov 17

PMID 19915847

Citations 35

Authors

Saskia G C van Elderen

A Brandts

J J M Westenberg

J van der Grond

J T Tamsma

M A van Buchem

J A Romijn

L J M Kroft

J W A Smit

A de Roos

Affiliations

Soon will be listed here.

Abstract

Objective: To evaluate, with the use of magnetic resonance imaging (MRI), whether aortic pulse wave velocity (PWV) is associated with cardiac left ventricular (LV) function and mass as well as with cerebral small vessel disease in patients with type 1 diabetes mellitus (DM).

Materials And Methods: We included 86 consecutive type 1 DM patients (49 male, mean age 46.9 +/- 11.7 years) in a prospective, cross-sectional study. Exclusion criteria included aortic/heart disease and general MRI contra-indications. MRI of the aorta, heart and brain was performed for assessment of aortic PWV, as a marker of aortic stiffness, systolic LV function and mass, as well as for the presence of cerebral white matter hyperintensities (WMHs), microbleeds and lacunar infarcts. Multivariate linear or logistic regression was performed to analyse the association between aortic PWV and outcome parameters, with covariates defined as age, gender, mean arterial pressure, heart rate, BMI, smoking, DM duration and hypertension.

Results: Mean aortic PWV was 7.1 +/- 2.5 m/s. Aortic PWV was independently associated with LV ejection fraction (ss = -0.406, P = 0.006), LV stroke volume (ss = -0.407, P = 0.001), LV cardiac output (ss = -0.458, P = 0.001), and with cerebral WMHs (P < 0.05). There were no independent associations between aortic stiffness and LV mass, cerebral microbleeds or lacunar infarcts.

Conclusion: Aortic stiffness is independently associated with systolic LV function and cerebral WMHs in patients with type 1 DM.

Citing Articles

Association of Left Ventricular Function With Cerebral Small Vessel Disease in a Community-Based Population.

Yang Y, Cai X, Zhou M, Chen Y, Pi J, Zhao M CNS Neurosci Ther. 2025; 31(2):e70226.

PMID: 39976242 PMC: 11840704. DOI: 10.1111/cns.70226.

Association between pulse wave velocity and cerebral microbleeds: a systematic review and meta-analysis.

Lever-Megina C, Cavero-Redondo I, Saz-Lara A, Moreno-Herraiz N, Rescalvo-Fernandez E, Otero-Luis I Hypertens Res. 2024; 48(1):314-326.

PMID: 39448810 DOI: 10.1038/s41440-024-01963-6.

Leukoaraiosis: Epidemiology, Imaging, Risk Factors, and Management of Age-Related Cerebral White Matter Hyperintensities.

Huang W, Lin Q, Tzeng C J Stroke. 2024; 26(2):131-163.

PMID: 38836265 PMC: 11164597. DOI: 10.5853/jos.2023.02719.

Associations of Cerebrovascular Regulation and Arterial Stiffness With Cerebral Small Vessel Disease: A Systematic Review and Meta-Analysis.

Scheuermann B, Parr S, Schulze K, Kunkel O, Turpin V, Liang J J Am Heart Assoc. 2023; 12(23):e032616.

PMID: 37930079 PMC: 10727345. DOI: 10.1161/JAHA.123.032616.

Haptoglobin genotype and its relation to asymptomatic cerebral small-vessel disease in type 1 diabetes.

Eriksson M, Syreeni A, Sandholm N, Dahlstrom E, Gordin D, Tatlisumak T Acta Diabetol. 2023; 60(6):749-756.

PMID: 36856861 PMC: 10148779. DOI: 10.1007/s00592-023-02059-2.

References

van der Meer R, Diamant M, Westenberg J, Doornbos J, Bax J, de Roos A . Magnetic resonance assessment of aortic pulse wave velocity, aortic distensibility, and cardiac function in uncomplicated type 2 diabetes mellitus. J Cardiovasc Magn Reson. 2007; 9(4):645-51. DOI: 10.1080/10976640601093703. View

ORourke M . Arterial aging: pathophysiological principles. Vasc Med. 2007; 12(4):329-41. DOI: 10.1177/1358863X07083392. View

Fazekas F, Chawluk J, Alavi A, Hurtig H, Zimmerman R . MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol. 1987; 149(2):351-6. DOI: 10.2214/ajr.149.2.351. View

Schram M, Chaturvedi N, Fuller J, Stehouwer C . Pulse pressure is associated with age and cardiovascular disease in type 1 diabetes: the Eurodiab Prospective Complications Study. J Hypertens. 2003; 21(11):2035-44. DOI: 10.1097/00004872-200311000-00012. View

Henskens L, Kroon A, van Oostenbrugge R, Gronenschild E, Fuss-Lejeune M, Hofman P . Increased aortic pulse wave velocity is associated with silent cerebral small-vessel disease in hypertensive patients. Hypertension. 2008; 52(6):1120-6. DOI: 10.1161/HYPERTENSIONAHA.108.119024. View

Palmieri V, Capaldo B, Russo C, Iaccarino M, Pezzullo S, Quintavalle G . Uncomplicated type 1 diabetes and preclinical left ventricular myocardial dysfunction: insights from echocardiography and exercise cardiac performance evaluation. Diabetes Res Clin Pract. 2007; 79(2):262-8. DOI: 10.1016/j.diabres.2007.09.014. View

Vermeer S, Longstreth Jr W, Koudstaal P . Silent brain infarcts: a systematic review. Lancet Neurol. 2007; 6(7):611-9. DOI: 10.1016/S1474-4422(07)70170-9. View

Giannattasio C, Failla M, Piperno A, Grappiolo A, Gamba P, Paleari F . Early impairment of large artery structure and function in type I diabetes mellitus. Diabetologia. 1999; 42(8):987-94. DOI: 10.1007/s001250051257. View

Oxlund H, Rasmussen L, Andreassen T, Heickendorff L . Increased aortic stiffness in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1989; 32(10):748-52. DOI: 10.1007/BF00274536. View

10.

Resnick L, Militianu D, Cunnings A, Pipe J, Evelhoch J, SOULEN R . Direct magnetic resonance determination of aortic distensibility in essential hypertension: relation to age, abdominal visceral fat, and in situ intracellular free magnesium. Hypertension. 1997; 30(3 Pt 2):654-9. DOI: 10.1161/01.hyp.30.3.654. View

11.

van Dijk E, Prins N, Vrooman H, Hofman A, Koudstaal P, Breteler M . Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke. 2008; 39(10):2712-9. DOI: 10.1161/STROKEAHA.107.513176. View

12.

Laurent S, Cockcroft J, van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D . Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006; 27(21):2588-605. DOI: 10.1093/eurheartj/ehl254. View

13.

Bell D . Heart failure: the frequent, forgotten, and often fatal complication of diabetes. Diabetes Care. 2003; 26(8):2433-41. DOI: 10.2337/diacare.26.8.2433. View

14.

Prins N, van Dijk E, den Heijer T, Vermeer S, Koudstaal P, Oudkerk M . Cerebral white matter lesions and the risk of dementia. Arch Neurol. 2004; 61(10):1531-4. DOI: 10.1001/archneur.61.10.1531. View

15.

Qiu C, Cotch M, Sigurdsson S, Garcia M, Klein R, Jonasson F . Retinal and cerebral microvascular signs and diabetes: the age, gene/environment susceptibility-Reykjavik study. Diabetes. 2008; 57(6):1645-50. DOI: 10.2337/db07-1455. View

16.

Ovbiagele B, Saver J . Cerebral white matter hyperintensities on MRI: Current concepts and therapeutic implications. Cerebrovasc Dis. 2006; 22(2-3):83-90. DOI: 10.1159/000093235. View

17.

ORourke M, Safar M . Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension. 2005; 46(1):200-4. DOI: 10.1161/01.HYP.0000168052.00426.65. View

18.

Ohmine T, Miwa Y, Yao H, Yuzuriha T, Takashima Y, Uchino A . Association between arterial stiffness and cerebral white matter lesions in community-dwelling elderly subjects. Hypertens Res. 2008; 31(1):75-81. DOI: 10.1291/hypres.31.75. View

19.

Greenberg S, Vernooij M, Cordonnier C, Viswanathan A, Salman R, Warach S . Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009; 8(2):165-74. PMC: 3414436. DOI: 10.1016/S1474-4422(09)70013-4. View

20.

Craft S, Watson G . Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol. 2004; 3(3):169-78. DOI: 10.1016/S1474-4422(04)00681-7. View